Subtopic Deep Dive

← Bioactive Compounds and Antitumor Agents

NAD(P)H:Quinone Oxidoreductase in Quinone Metabolism
Research Guide

What is NAD(P)H:Quinone Oxidoreductase in Quinone Metabolism?

NAD(P)H:quinone oxidoreductase 1 (NQO1), also known as DT-diaphorase, is a flavoprotein enzyme that catalyzes the two-electron reduction of quinones to hydroquinones, preventing reactive oxygen species formation in quinone metabolism.

NQO1 detoxifies quinones from bioactive compounds like naphthoquinones and estrogen metabolites, modulating cytotoxicity in cancer cells. Polymorphisms in NQO1 affect enzyme activity and tumor sensitivity to quinone-based agents. Over 350 citations document its role in 17AAG antitumor activity (Kelland et al., 1999).

Curated Papers

Key Challenges

Why It Matters

NQO1 expression influences tumor cell sensitivity to 17-allylamino-17-demethoxygeldanamycin (17AAG), an HSP90 inhibitor, with high DT-diaphorase levels enhancing cytotoxicity (Kelland et al., 1999, 350 citations). NQO1 polymorphisms predict patient responses to quinone anticancer therapies, as shown in high-throughput genotyping studies (Shi et al., 1999, 78 citations). Naphthoquinones target trypanosomes and cancer via redox cycling modulated by NQO1-like activities (Pinto and de Castro, 2009, 205 citations). Coumarins activate Nrf2/ARE pathway via NQO1 induction for oxidative stress protection in tumors (Hassanein et al., 2020, 235 citations).

Key Research Challenges

NQO1 Polymorphism Variability

NQO1 single nucleotide polymorphisms reduce enzyme activity, altering quinone detoxification and drug sensitivity across populations. High-throughput TaqMan genotyping detects these variants but requires scaling for clinical use (Shi et al., 1999). Tumor-specific expression complicates predictions (Kelland et al., 1999).

Quinone Redox Cycling Toxicity

One-electron reduction of quinones generates semiquinones and ROS, while NQO1's two-electron path detoxifies; balancing this is key for anticancer selectivity. Naphthoquinones exploit this in tumors but risk normal cell damage (Pinto and de Castro, 2009). Short-chain quinones like idebenone modulate mitochondrial redox via NQO1 (Erb et al., 2012).

Tumor-Specific NQO1 Expression

Heterogeneous NQO1 levels in tumors affect sensitivity to agents like 17AAG, requiring biomarkers for patient stratification. Monitoring polymorphisms and activity is essential (Kelland et al., 1999). Nrf2 induction upregulates NQO1 variably across cancer types (Hassanein et al., 2020).

Essential Papers

DT-Diaphorase Expression and Tumor Cell Sensitivity to 17-Allylamino,17-demethoxygeldanamycin, an Inhibitor of Heat Shock Protein 90

LR Kelland, Swee Y. Sharp, Paul Rogers et al. · 1999 · JNCI Journal of the National Cancer Institute · 350 citations

These results suggest that the antitumor activity and possibly the toxicologic properties of 17AAG in humans may be influenced by the expression of DT-diaphorase. Careful monitoring for NQO1 polymo...

Coumarins as Modulators of the Keap1/Nrf2/ARE Signaling Pathway

Emad H. M. Hassanein, Ahmed M. Sayed, Omnia E. Hussein et al. · 2020 · Oxidative Medicine and Cellular Longevity · 235 citations

The Keap1/Nrf2/ARE system is a central defensive mechanism against oxidative stress which plays a key role in the pathogenesis and progression of many diseases. Nrf2 is a redox-sensitive transcript...

The Trypanocidal Activity of Naphthoquinones: A Review

António Pinto, Solange L. de Castro · 2009 · Molecules · 205 citations

Naphthoquinones are compounds present in several families of higher plants. Their molecular structures confer redox properties, and they are involved in multiple biological oxidative processes. In ...

The diverse mechanisms and anticancer potential of naphthoquinones

Carolina Escardó Pereyra, Rafael Ferreira Dantas, Sabrina Baptista Ferreira et al. · 2019 · Cancer Cell International · 192 citations

Biosynthesis and molecular actions of specialized 1,4-naphthoquinone natural products produced by horticultural plants

Joshua R. Widhalm, David Rhodes · 2016 · Horticulture Research · 167 citations

The 1,4-naphthoquinones (1,4-NQs) are a diverse group of natural products found in every kingdom of life. Plants, including many horticultural species, collectively synthesize hundreds of specializ...

Resveratrol Prevents Estrogen-DNA Adduct Formation and Neoplastic Transformation in MCF-10F Cells

Fang Lü, Muhammad Zahid, Cheng Wang et al. · 2008 · Cancer Prevention Research · 108 citations

Abstract Exposure to estrogens is a risk factor for breast cancer. Specific estrogen metabolites may initiate breast cancer and other cancers. Genotoxicity may be caused by cytochrome P450 (CYP)–me...

Features of Idebenone and Related Short-Chain Quinones that Rescue ATP Levels under Conditions of Impaired Mitochondrial Complex I

Michael A. Erb, Barbara Hoffmann-Enger, H. Deppe et al. · 2012 · PLoS ONE · 95 citations

Short-chain quinones have been investigated as therapeutic molecules due to their ability to modulate cellular redox reactions, mitochondrial electron transfer and oxidative stress, which are patho...

Reading Guide

Foundational Papers

Start with Kelland et al. (1999, 350 citations) for NQO1's role in 17AAG tumor sensitivity and polymorphism monitoring; Shi et al. (1999, 78 citations) for genotyping methods; Pinto and de Castro (2009, 205 citations) for naphthoquinone redox basics.

Recent Advances

Hassanein et al. (2020, 235 citations) on Nrf2/NQO1 induction by coumarins; Pereyra et al. (2019, 192 citations) on naphthoquinone anticancer mechanisms; Widhalm and Rhodes (2016, 167 citations) on 1,4-naphthoquinone biosynthesis.

Core Methods

TaqMan probes for SNP genotyping (Shi et al., 1999); DT-diaphorase activity assays in cell lines (Kelland et al., 1999); FMN-dependent superfamily analysis for azoreductase-NQO1 homology (Ryan et al., 2014).

How PapersFlow Helps You Research NAD(P)H:Quinone Oxidoreductase in Quinone Metabolism

Discover & Search

Research Agent uses searchPapers and exaSearch to find NQO1-quinone papers like 'DT-Diaphorase Expression and Tumor Cell Sensitivity' (Kelland et al., 1999), then citationGraph reveals 350 citing works on polymorphisms, and findSimilarPapers uncovers naphthoquinone reviews (Pinto and de Castro, 2009).

Analyze & Verify

Analysis Agent applies readPaperContent to extract NQO1 activity data from Kelland et al. (1999), verifies claims with CoVe against 17AAG sensitivity assays, and runs PythonAnalysis on citation counts or polymorphism frequencies using pandas for statistical validation; GRADE scores evidence strength for tumor expression claims.

Synthesize & Write

Synthesis Agent detects gaps in NQO1 inhibitor studies across cancers, flags contradictions in redox mechanism papers; Writing Agent uses latexEditText for quinone pathway diagrams, latexSyncCitations for 10+ references, and latexCompile to generate review sections with exportMermaid for NQO1 reaction graphs.

Use Cases

"Analyze NQO1 polymorphism frequency in breast cancer cohorts from recent papers"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas aggregation of genotype data from Shi et al., 1999) → CSV export of prevalence stats with p-values.

"Write LaTeX section on NQO1 role in 17AAG sensitivity with figure"

Research Agent → citationGraph (Kelland 1999) → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexGenerateFigure (enzyme kinetics plot) → latexSyncCitations → latexCompile → PDF output.

"Find GitHub repos with NQO1 quinone docking simulations"

Research Agent → paperExtractUrls (Ryan et al., 2014 azoreductase models) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for FMN-binding analysis.

Automated Workflows

Deep Research workflow scans 50+ NQO1 papers via searchPapers, structures report on polymorphism impacts with GRADE grading. DeepScan applies 7-step CoVe to verify quinone cytotoxicity claims from Kelland et al. (1999) against naphthoquinone reviews. Theorizer generates hypotheses on NQO1 inhibitors from Nrf2 pathway papers (Hassanein et al., 2020).

Try Doxa for NAD(P)H:Quinone Oxidoreductase in Quinone Metabolism Research

Frequently Asked Questions

What is the definition of NAD(P)H:quinone oxidoreductase (NQO1)?

NQO1 is a flavoprotein that performs two-electron reduction of quinones to hydroquinones, avoiding semiquinone radicals (Kelland et al., 1999).

What are key methods for studying NQO1 in quinone metabolism?

High-throughput TaqMan genotyping detects NQO1 polymorphisms (Shi et al., 1999); activity assays measure DT-diaphorase in tumor cells (Kelland et al., 1999).

What are key papers on NQO1 and antitumor agents?

Kelland et al. (1999, 350 citations) links NQO1 to 17AAG sensitivity; Pinto and de Castro (2009, 205 citations) reviews naphthoquinone trypanocidal activity via quinone reduction.

What are open problems in NQO1 quinone research?

Challenges include predicting tumor NQO1 levels for therapy and designing inhibitors that exploit polymorphisms without off-target ROS (Kelland et al., 1999; Shi et al., 1999).